After a relatively strong first half of its fiscal year, Cantel Medical (NYSE: CMD) slowed down a little in its third fiscal quarter. And things don't look like they're going to pick up anytime soon with the medical device maker lowering revenue guidance for the fiscal year, causing shares to drop 16% yesterday.MetricQ3 2018Continue reading